{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-003021","form_type":"8-K","ticker":"ISCO","cik":"0001355790","company_name":"International Stem Cell CORP","filed_at":"2022-04-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:00.348367+00:00","generated_at":"2026-06-26T02:31:07.220439+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"International Stem Cell appoints Dr. Russell Kern as principal financial officer; granted 1M options, salary $130K","bullets":["Dr. Russell Kern appointed principal financial officer effective April 25, 2022.","He continues as EVP and Chief Scientific Officer.","Granted options to purchase 1,000,000 shares of common stock.","Salary increased to $130,000 per year.","Biographical information incorporated from 2022 Proxy Statement."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-003021","json":"https://secwatch.observer/filing/0001683168-22-003021.json","markdown":"https://secwatch.observer/filing/0001683168-22-003021.md","text":"https://secwatch.observer/filing/0001683168-22-003021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355790/000168316822003021/0001683168-22-003021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355790/000168316822003021/isco-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:31:07.220439+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8add36b368","claim":"Russell Kern was appointed as principal financial officer at International Stem Cell CORP.","evidence_excerpt":"On April 25, 2022, International Stem Cell Corporation, a Delaware corporation (the “Company”) appointed Dr. Russell Kern as its principal financial officer effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1355790/000168316822003021/0001683168-22-003021-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"principal financial officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}